Holen Sie sich die Stockscreener-App
429.11
0.85%
-3.69
Handel nachbörslich:
436.06
6.95
+1.62%
Schlusskurs vom Vortag:
$432.80
Offen:
$443.5351
24-Stunden-Volumen:
293.53K
Relative Volume:
0.78
Marktkapitalisierung:
$12.26B
Einnahmen:
$2.68B
Nettoeinkommen (Verlust:
$460.40M
KGV:
26.99
EPS:
15.8963
Netto-Cashflow:
$711.00M
1W Leistung:
+2.19%
1M Leistung:
+4.52%
6M Leistung:
-29.26%
1J Leistung:
+45.52%
1-Tages-Spanne:
$422.88
$443.54
1-Wochen-Bereich:
$403.46
$443.54
52-Wochen-Spanne:
$291.28
$628.92
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, WAT, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
429.11 | 12.36B | 2.68B | 460.40M | 711.00M | 15.90 |
TMO
Thermo Fisher Scientific Inc
|
448.18 | 166.59B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.81 | 121.74B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.21 | 44.12B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
338.64 | 33.62B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
115.08 | 32.49B | 7.07B | 1.29B | 993.00M | 4.5355 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2026-03-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-18 | Hochstufung | TD Cowen | Sell → Hold |
| 2026-02-13 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-02 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-09-03 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-29 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-23 | Herabstufung | TD Cowen | Hold → Sell |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
| 2024-08-01 | Eingeleitet | Truist | Hold |
| 2024-05-29 | Eingeleitet | TD Cowen | Buy |
| 2024-05-28 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-15 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-27 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-07 | Eingeleitet | UBS | Sell |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-10-02 | Hochstufung | Truist | Hold → Buy |
| 2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
| 2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
| 2018-09-17 | Eingeleitet | SunTrust | Hold |
| 2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, - GlobeNewswire
INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMEDP - PR Newswire
Portnoy Law Firm Announces Class Action on Behalf of Medpace Holdings, Inc. Investors - GlobeNewswire
MEDP Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Medpace Holdings, Inc. Securities LawsuitContact The Gross Law Firm - PR Newswire
MEDP Court Notification: Medpace Cancellation Rates and Corresponding 16% Stock Drop Trigger Shareholder Class Action for Securities Fraud - TradingView
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
MEDP Stockholders Have Opportunity to Lead Medpace Holdings, Inc - The National Law Review
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Medpace Holdings, Inc. to Contact the Firm Today! - ACCESS Newswire
$MEDP Shareholder Announcement: Medpace may have Misled - GlobeNewswire
Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth In The Healthcare Sector - DirectorsTalk Interviews
MEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - TMX Newsfile
MEDP Stockholders Have Opportunity to Lead Medpace Holdings, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP AnnouncesMEDP - lincolnjournal.com
MEDP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - TMX Newsfile
Kohl’s, Medpace, General Motors, Lockheed Martin, Northrop Grumman: Stocks Making The Biggest Moves Today - MSN
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
MEDP Technical Analysis | Trend, Signals & Chart Patterns | MEDPACE HOLDINGS INC (NASDAQ:MEDP) - ChartMill
ROSEN, A LONGSTANDING LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMEDP - TMX Newsfile
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Laws - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming DeadlinesMEDP - PR Newswire
INVESTOR ALERT: Medpace Holdings Inc. Investors with - GlobeNewswire
Turtle Creek Asset Management Inc.'s Medpace Holdings Inc(MEDP) Holding History - GuruFocus
Deadline Alert: Medpace Holdings, Inc. (MEDP) Shareholders - GlobeNewswire
MEDP EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - PR Newswire
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Cancellation Rate Risks: SueWallSt - Morningstar
$MEDP Notification: Medpace Cancellation Rates Lead to Securities Fraud Class Action after 16% Stock Drop - ACCESS Newswire
$MEDP Stock Drop Notice: Medpace Stock Dropped 16% Leading to a Shareholder Securities Fraud Class ActionInvestors Notified of June 8 Deadline - ACCESS Newswire
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Medpace Holdings, Inc. – MEDP - ACCESS Newswire
Lead Plaintiff Deadline of June 8, 2026 in Shareholder - GlobeNewswire
MEDP Securities Class Action: Medpace 16% Stock Drop - GlobeNewswire
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What Are the Core Allegations Against Medpace (MEDP) - Kavout
Medpace shareholders approve bylaw changes and board elections at annual meeting - Investing.com India
Medpace shareholders approve governance changes enhancing voting rights - TipRanks
Medpace (NASDAQ: MEDP) holders approve charter, bylaw changes and pay votes - Stock Titan
MEDP Deadline Alert: Medpace Investors with Losses are Notified - GuruFocus
Medpace Holdings stock (US5840631062): what the latest earnings mean for investors - AD HOC NEWS
MEDP Deadline Alert: Medpace Investors with Losses are Notified of the Pending Securities Fraud Class Action Over Alleged Misrepresentations - TradingView
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
MEDP Stock Chart | MEDPACE HOLDINGS INC (NASDAQ:MEDP) - ChartMill
ROSEN, LEADING INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel ... - Caledonian Record
ROSEN, LEADING INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC - GlobeNewswire Inc.
Pomerantz LLP Issues Important Reminder to Medpace Holdings, Inc. Investors – MEDP - ACCESS Newswire
Medpace flags rising cancellations, near-term growth uncertain - MSN
Medpace (MEDP) director Dani S. Zander receives stock options grant - Stock Titan
Medpace (MEDP) director receives 1,110 stock options at $415.27 strike price - Stock Titan
Medpace (MEDP) director granted 1,110 options at $415.27 per share - Stock Titan
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Medpace Holdings Inc-Aktie (MEDP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Brady Kevin M. | CFO & Treasurer |
Apr 24 '26 |
Option Exercise |
138.87 |
7,000 |
972,090 |
12,830 |
| BURWIG SUSAN E | Exec. VP, Operations |
Mar 18 '26 |
Option Exercise |
166.73 |
12,000 |
2,000,760 |
70,484 |
| GEIGER JESSE J | President |
Mar 17 '26 |
Option Exercise |
138.87 |
31,707 |
4,403,151 |
46,707 |
| GEIGER JESSE J | President |
Mar 17 '26 |
Sale |
455.30 |
31,707 |
14,436,197 |
15,000 |
1.19%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):